Jaton T, Thonney M, Guignard J P
Service de Pédiatrie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Dev Pharmacol Ther. 1991;17(3-4):161-6. doi: 10.1159/000457517.
The renal effects of dopexamine, a new dopaminergic agonist devoid of any alpha-adrenergic effect, were studied in 11 anesthetized newborn rabbits undergoing an acute hypoxemic normocapnic stress. Acute hypoxemia (PaO2 = 41 mm Hg) was associated with a marked increase in renal vascular resistance and a consequent decrease in glomerular filtration rate and renal blood flow. These changes were not modified by the administration of dopexamine at 10 micrograms/kg/min. Failure of dopexamine to blunt the hypoxemia-induced vaso-constriction suggests vascular dopaminergic receptor immaturity.
在11只接受急性低氧性等碳酸血症应激的麻醉新生兔中,研究了多培沙明(一种无任何α-肾上腺素能效应的新型多巴胺能激动剂)对肾脏的影响。急性低氧血症(动脉血氧分压=41mmHg)与肾血管阻力显著增加以及肾小球滤过率和肾血流量随之降低有关。以10微克/千克/分钟的剂量给予多培沙明并未改变这些变化。多培沙明未能减轻低氧血症诱导的血管收缩,提示血管多巴胺能受体不成熟。